BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38159996)

  • 21. Clinical and prognostic significance of preoperative lymphocyte-monocyte ratio, neutrophil-lymphocyte ratio and neutrophil-monocyte ratio on esophageal squamous cell carcinoma patients.
    Shang QX; Yang YS; Hu WP; Yuan Y; He Y; Zhao JY; Ji AF; Chen LQ
    Transl Cancer Res; 2020 Jun; 9(6):3903-3914. PubMed ID: 35117757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
    Fu X; Li T; Dai Y; Li J
    BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
    Yang HM; Lou G
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
    [No Abstract]   [Full Text] [Related]  

  • 24. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
    Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
    World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of pre-treatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.
    Yu B; Ma SJ; Khan M; Gill J; Iovoli A; Fekrmandi F; Farrugia MK; Wooten K; Gupta V; McSpadden R; Kuriakose MA; Markiewicz MR; Al-Afif A; Hicks WL; Seshadri M; Ray AD; Repasky EA; Singh AK
    BMC Cancer; 2023 Jun; 23(1):572. PubMed ID: 37344761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma.
    Zhao K; Wang C; Shi F; Li M; Yu J
    Transl Cancer Res; 2020 Jun; 9(6):3842-3853. PubMed ID: 35117751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Prognostic Impact of the Lymphocyte-to-Monocyte Ratio in Resected Pancreatic Head Adenocarcinoma.
    Onoe S; Maeda A; Takayama Y; Fukami Y; Takahashi T; Uji M; Kaneoka Y
    Med Princ Pract; 2019; 28(6):517-525. PubMed ID: 31104057
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer with special reference to myeloid-derived suppressor cells.
    Shimura T; Shibata M; Gonda K; Hayase S; Sakamoto W; Okayama H; Fujita S; Saito M; Momma T; Ohki S; Kono K
    Fukushima J Med Sci; 2018 Aug; 64(2):64-72. PubMed ID: 30012939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy.
    Li KJ; Xia XF; Su M; Zhang H; Chen WH; Zou CL
    BMC Cancer; 2019 Oct; 19(1):1004. PubMed ID: 31655563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The predictive value of lymphocyte to monocyte ratio for overall survival in cholangiocarcinoma patients with hepatic resection.
    Lv M; Wang K; Zhang Z; Zhang Z; Wan J
    Cancer Med; 2023 Apr; 12(8):9482-9495. PubMed ID: 36825605
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphocyte-to-monocyte ratio is an independent prognostic factor in surgically treated small cell lung cancer: An international multicenter analysis.
    Lang C; Egger F; Alireza Hoda M; Saeed Querner A; Ferencz B; Lungu V; Szegedi R; Bogyo L; Torok K; Oberndorfer F; Klikovits T; Schwendenwein A; Boettiger K; Renyi-Vamos F; Hoetzenecker K; Schelch K; Megyesfalvi Z; Dome B
    Lung Cancer; 2022 Jul; 169():40-46. PubMed ID: 35643059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis.
    Kim D; Bae SJ; Ahn SG; Jeong J; Park S; Park WC; Park G; Lee S; Yoon CI
    Breast Cancer Res Treat; 2022 Jun; 193(3):637-647. PubMed ID: 35426542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment lymphocyte-monocyte ratio (LMR) as a superior predictor of short-term progression outcomes in patients with gastric cancer receiving second- and later-line apatinib regimens.
    Shen H; Dang W; Su R; Zhang Z; Wu S; Li M; Liu X; He Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10715-10726. PubMed ID: 37308747
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of systemic inflammatory response markers in patients with superficial esophageal squamous cell carcinomas.
    Chen CJ; Lee CT; Tsai YN; Tseng CM; Chen TH; Hsu MH; Wang CC; Wang WL
    Sci Rep; 2022 Oct; 12(1):18241. PubMed ID: 36309551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocyte-to-monocyte ratio combined with CA19-9 for predicting postoperative recurrence of colorectal cancer in patients with diabetes.
    Yu D; An G; Yao J
    J Clin Lab Anal; 2021 Sep; 35(9):e23944. PubMed ID: 34418175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma.
    Hutterer GC; Stoeckigt C; Stojakovic T; Jesche J; Eberhard K; Pummer K; Zigeuner R; Pichler M
    Urol Oncol; 2014 Oct; 32(7):1041-8. PubMed ID: 25027686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of lymphocyte to monocyte ratio in pancreatic cancer: a systematic review and meta-analysis including 3338 patients.
    Lin S; Fang Y; Mo Z; Lin Y; Ji C; Jian Z
    World J Surg Oncol; 2020 Jul; 18(1):186. PubMed ID: 32711514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive Value of a Prognostic Model Based on Lymphocyte-to-Monocyte Ratio Before Radioiodine Therapy for Recurrence of Papillary Thyroid Carcinoma.
    Zhou C; Duan D; Liu S
    Technol Cancer Res Treat; 2021; 20():15330338211027910. PubMed ID: 34191658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of Pre-treatment Lymphocyte/Monocyte Ratio and Neutrophil/Lymphocyte Ratio on the Prognosis of Patients with Extranodal NK/T-Cell Lymphoma].
    Deng XY; Wang YY; Dang QQ; Liang TS; Zheng YJ; Yang DK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):707-713. PubMed ID: 37356930
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low Preoperative Lymphocyte to Monocyte Ratio Serves as a Worse Prognostic Marker in Patients with Esophageal Squamous Cell Carcinoma Undergoing Curative Tumor Resection.
    Song Q; Wu JZ; Wang S
    J Cancer; 2019; 10(9):2057-2062. PubMed ID: 31205566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.